Chapter 28: Tetracyclines, Aminoglycosides & Fluoroquinolones

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

Today we are opening up a file that, I'll be honest, usually makes people sweat a little.

Just a little.

We are looking at the heavy machinery of the pharmaceutical world.

We're talking about drugs that save lives in the ICU but carry risks that can alter a patient's life permanently if you aren't paying, you know, close attention.

It's so true.

This is not the take two aspirin and call me in the morning category.

Not at all.

This is the measure the blood levels every few hours and monitor urine output strictly category.

We are dealing with some very potent biology here.

We are diving deep into Chapter 28 of pharmacology, a patient -centered nursing process approach, the 12th edition.

And our mission today is to unpack four specific high -stakes groups of antibacterials, tetracyclines, glycylcyclines, aminoglucosides, and fluoroquinolones.

Mouthful.

It is.

And I want to be clear right off the bat, this is a specialized deep dive.

We are constructing this specifically for nursing students or really anyone who wants to understand the nurse thinking required to manage these powerful bioagents safely.

And that phrase, nurse thinking, that's everything.

A lot of people think pharmacology is just memorizing a flash card, you know, drug name equals disease cured.

Right.

But that is dangerous thinking.

With these drugs, it's all about the margin of error.

We're going to look at the mechanisms, how they actually dismantle bacteria.

But more importantly, we're going to focus on the red flags.

Why does one turn teeth gray?

Why can another one literally snap an Achilles tendon?

Which sounds like a myth, but as I've learned from reading this chapter, it is definitely not a myth.

It is definitely not a myth.

It is a physiological biochemical reality.

Wow.

So here's our roadmap for the next hour or so.

We are sticking strictly to the flow of the text in Chapter 28.

We're going to start with the older broad spectrum pioneers, move into the synthetic upgrades, and then tackle the really, really potent bactericidal agents where the toxicity risks just skyrocket.

We have the last minute lecture notes to help us synthesize the black box warnings and tables.

So we're going to weave all that data into a conversational guide.

Let's get into it.

Okay.

Section one, the Tetracyclines.

These are often described as the broad spectrum pioneers.

When you look at the history here, it really is a post -World War II breakthrough, isn't it?

It is.

It's a huge moment.

The text highlights that the first Tetracycline was isolated from a bacterium called Streptomyces aureofaciens in 1948.

Now, before this, we had penicillin, but penicillin was limited.

It was great, but it had narrow length.

It was a specialist.

A specialist, exactly.

Tetracyclines changed the whole landscape because they were the first true broad spectrum antibiotics.

They worked on gram positive bacteria, sure, but they also hammered gram negatives.

It was like moving from a sniper rifle to a shotgun.

Now, before we list what they kill, I want to understand the how.

The text uses the term For anyone listening who's not a microbiologist, what's the difference between that and bactericidal?

It's a crucial distinction.

It really dictates how we use the drug and what we expect from it.

Bactericidal drugs, like the amyglycosides we'll talk about later, they kill the bacteria directly.

They're assassins.

They blow up a cell wall or they destroy the DNA.

Right.

They go for the kill.

They go for the kill.

Tetracyclines are more like saboteurs.

They are a bacteriostatic.

They sneak into the bacterial cell and they bind to something called the 30S ribosomal subunit.

It's a protein factory.

Exactly.

The protein factory.

They inhibit protein synthesis.

So they stop the bacteria from manufacturing the proteins it needs to grow and reproduce.

They don't explode the cell.

They just pause the invasion.

So they just hit the pause button.

Right.

This stops the bacterial population from expanding, which gives the body's own immune system the time it needs to swoop in and finish the job.

So it sort of levels the playing field for the white blood cells.

That's a great way to put it.

It holds the enemy down so your immune system can land the knockout punch.

And because they target that protein synthesis mechanism, they have a really wide spectrum.

The text lists things like E.

coli and Klebsiella.

The common ones.

The common ones, though we have to be honest, resistance is a major, major issue with those books now.

We just overuse them for decades.

Makes sense.

But tetracyclines are still the absolute go -to for some specific tricky organisms.

Things like rickettsies, things like Rocky Mountain spotted fever and chlamydia.

For those, they're still a first line drug.

I noticed the text explicitly says they generally aren't effective against Staphylococcus aureus.

Generally, no.

Staphylococcus aureus and especially the methicillin resistant strains, you know, MRSA.

The super bug.

The super bug.

It usually just laughs at older tetracyclines.

Now, there are newer generations, which we will get to, that have been engineered to fight back.

But if you have a patient with a standard staph infection,

old school tetracycline is not your first card to play.

It also struggles with Pseudomonas, which is a bug we will talk about a lot today.

OK, so if they aren't for staph and resistance is rising in common bugs, why are they still such a massive part of the pharmacopitae?

I see two specific therapeutic uses highlighted in the text that seem to keep them in business.

Oh, yeah, there are two huge clinical niches for these drugs that are I mean, they're indispensable.

The first one is in the gut for Helicobacter pylori.

The ulcer bug.

The ulcer bug.

Exactly.

H.

pylori is incredibly stubborn.

You can't just throw one drug at it.

It burrows into the stomach lining and kind of protects itself.

Right.

So the text outlines a specific protocol where ketracycline is used in combination with metronidazole and bismuth sub salicylate.

Bismuth sub salicylate.

That's basically Pepto -Bismol, right?

Effectively, yes.

That trio, the antibiotic punch plus the bismuth, is often what's required to finally eradicate the bacteria and let those peptic ulcers heal.

It's a multi -pronged attack.

You hit it from all sides.

And the second use, this one feels like a rite of passage for teenagers.

Acne vulgaris.

Yeah, yeah.

And this is interesting pharmacology because the dosing strategy is totally different.

How so?

Well, for a big infection like pneumonia, you want high levels fast.

You want to saturate the blood.

For acne, we often use oral or topical tetracyclines at much lower doses over a longer period of time.

So it's more of a maintenance thing.

Exactly.

The goal isn't just killing bacteria.

It's about managing the skin flora and the inflammation to prevent those deep cystic breakouts.

It's a different approach entirely.

Now, let's pivot to the safety profile, because looking at the pharmacokinetic section, this is where things get really tricky.

There is a lot of chemistry happening in the stomach that a nurse or a patient needs to be aware of.

This is the binding problem.

And if you remember nothing else about tetracyclines from this deep dive, you have to remember this.

These drugs are chemically attracted to minerals,

specifically divalent and trivalent indications.

In plain English.

Calcium, magnesium, aluminum, and iron.

Okay, the stuff in milk and antacids.

Exactly.

Tetracyclines love them.

They want to like hug them.

So if you take a tetracycline pill and at the same time you drink a big glass of milk.

Which has calcium.

Right.

Or you take an antacid like Tums, which is full of magnesium or aluminum, or you take an iron supplement,

the drug will chemically bind to those minerals right there in your stomach.

It's called chelation.

And what happens to that bound complex?

Does it just not work as well?

It doesn't work at all.

It becomes an insoluble precipitate.

It turns into a little rock, essentially.

Your body cannot absorb it.

Wow.

It just passes right through the GI tract.

So you might have taken the pill, but therapeutically, it's as if you took a placebo.

You neutralize the weapon before it even entered the bloodstream.

That is a massive patient teaching point.

The do not mix list is strict.

Very strict.

No Tums, no milk, no iron pills, no multivitamins with zinc.

You have to be a detective about what else the patient is putting in their mouth.

So what is the administration rule then, if I'm advising a patient?

The classic rule is empty stomach.

You want to take it one hour before meals or two hours after meals.

So you've got that three hour window.

Exactly.

You need an acidic environment without those minerals floating around to get proper absorption.

However,

I'm looking at the notes here.

And in true pharmacology fashion, there is a big exception.

There is always an exception.

Always.

And this one is vital because these are the drugs you actually see prescribed most often today.

Doxycycline and minocycline.

How are they different?

They are still tetracyclines, right?

They are, but they're what we call lipid soluble.

They're synthetic upgrades.

Because of their chemical structure, they are actually absorbed better when taken with food.

Oh, wow.

So it's the opposite.

It's the opposite.

And while calcium can still be a minor issue, it's nowhere near the problem it is with the older drugs.

So doxycycline and minocycline generally can be taken with food, which helps a lot because these drugs can be tough on the stomach.

They can cause some nausea.

So having food on board helps with that.

Right.

It helps with compliance.

It's easier to take a pill with a meal than on an empty stomach when it's making you feel sick.

That is a huge distinction.

Old school, petracycline.

Empty stomach, suffering, doxycycline.

Food is okay.

Milk is surprisingly okay.

Correct.

You have to check the specific drug name.

You absolutely cannot apply the empty stomach rule blindly to the whole class anymore.

That's a classic mistake.

Okay.

Let's move to section two.

Side effects.

Yeah.

Honestly, this list reads like a warning label from a sci -fi movie.

We have the standard nausea and vomiting, which is par for the course with antibiotics.

Pretty common, yeah.

But then we have photosensitivity.

Yes.

This is a classic board exam question and a real life misery for patients.

Tetracyclines and the text specifically points a finger at demyclocycline for this.

Sensitize the skin to ultraviolet light.

So we aren't talking about just getting a tan faster.

This is something else.

We are talking about a rapid, severe, blistering sunburn reaction.

You can go outside for 20 minutes on a cloudy day and come back looking like a lobster.

It's a really exaggerated burn response.

Wow.

The patient teaching here is non -negotiable, strong sunblock, long sleeves, hats, or just stay out of the sun entirely while on the course.

Then there's the warning that scares every parent, the teeth and bones warning.

This goes right back to that calcium binding we just discussed.

The drug loves calcium.

Where do you have the most calcium in your body?

Bones and teeth.

Exactly.

So if this drug is circulating in the blood of someone who is building those structures, it will deposit itself into the calcium matrix of forming teeth and bones.

It literally integrates into the structure.

And if those teeth are currently developing, say, in a child?

It alters the structure and the color.

If you give tetracyclines to a woman in the last trimester of pregnancy or to a child younger than eight years old, the drug binds to the tooth buds.

When those permanent teeth finally erupt years later, they won't be white.

They will be gray or yellow or brown.

And that's permanent.

You can't just bleach that out at the dentist.

No, it's intrinsic.

It's part of the enamel structure itself.

It is irreversible discoloration.

That is why this drug is strictly, strictly contraindicated for children under eight and during pregnancy.

It can also affect skeletal growth in the fetus.

It's just a hard no for pregnancy in general.

There's another safety warning here that I found really specific and kind of terrifying.

The outdated medication warning.

Usually when a drug expires, we just assume it stops working, it gets weaker.

Usually potency is the issue.

Tetracyclines are the dangerous exception.

When they degrade over time, they break down into a toxic byproduct.

If you take expired tetracycline, it can cause a condition similar to Fanconi syndrome.

It causes severe damage to the proximal renal tubules in the kidney.

So checking the expiration date isn't just bureaucratic.

It's a toxicity prevention measure.

Absolutely.

If you find an old bottle in the back of the cabinet from three years ago, do not take it.

Throw it out.

You could put yourself in kidney failure.

It's that serious.

We also need to touch on mannocycline specifically.

It has a unique side effect profile regarding the inner ear, doesn't it?

It does.

It can cause vestibular toxicity.

So patients might complain of dizziness, lightheadedness, or vertigo.

That feeling like the room is spinning.

So it affects their balance.

Exactly.

If a patient on mannocycline starts stumbling or feels unsafe driving,

that's a huge red flag to stop the medication.

It's affecting the balance center in the inner ear.

And finally, under toxicity, there's the risk of super infection.

Which, you know, it makes sense given how broad spectrum these are.

They kill the bacteria causing your infection, but they also carpet bomb the good normal flora in your mouth, gut, and vagina.

Which opens the door for other things.

It opens the door for opportunistic pathogens.

You might cure the acne, but end up with a severe yeast infection, which is Candida, or even C.

diff colitis.

C.

diff is a big one.

It is.

Nurses need to be watching for that secondary round of symptoms.

If the patient gets diarrhea while on these drugs, you don't just give him modium.

You have to investigate.

You have to check for C.

diff.

Let's look at section three and table 28 .1.

This breaks down the classification by duration.

It helps to group them.

We have short, intermediate, and long acting.

Right.

And the short acting is just plain old tetracycline.

We talked about its use as acne, H.

pylori.

The downside is the half -life.

It's short.

So you have to take it more often.

A lot more often.

Usually every six hours.

That's four times a day.

And compliance becomes a real issue there.

It's hard to remember to take a pill four times a day, especially on an empty stomach.

Then intermediate acting, which is Demyclocycline.

Demyclocycline is an interesting one.

The text lists it for acne and some pretty serious things like anthrax and plague.

But clinically, you'll sometimes see it used for something completely different.

SIADH, or syndrome of inappropriate antidiuretic hormone.

Really?

Yeah.

It actually blocks ADH in the kidney.

But for the purpose of this infectious disease chapter, just know it stays in the system longer, allowing for twice daily dosing, which is better.

And then the long acting group.

We mentioned doxycycline and minocycline.

Doxycycline is really the workhorse of the modern class.

It's used for everything from Lyme disease to anthrax to malaria prophylaxis to STIs.

It's incredibly versatile.

And minocycline?

Minocycline is the heavy hitter for MRSA and skin infections.

These are usually once or twice daily, which patients much prefer.

I also see two very new names here.

Omadacycline and Aravecycline.

These are the new generation.

They were designed specifically to overcome the resistance mechanisms that bacteria developed against the older tetracyclines.

How so?

Bacteria learned how to pump the old drugs out of their cells.

It's like they installed an ejector seat.

Okay.

These new ones are designed to stay in.

They're stickier.

Omadacycline is a beast against community acquired pneumonia and skin infections.

Aravecycline is used for really complicated intra -abdominal infections.

And looking at omadacycline, there is a specific dosing concept mentioned.

The loading dose.

What's that about?

Yes, you'll see this in the table.

The pharmacokinetics require a jumpstart.

On day one, you give a heavy dose, maybe 200 milligrams or multiple doses, to saturate the tissues and get the serum levels up to a therapeutic range really quickly.

So you flood the system first.

You flood it.

Then once you're at that level, you drop down to a maintenance dose, usually 100 milligrams, just to keep it there.

If you skip that loading dose, it might take days to reach effective levels.

And bacteria don't wait.

All right.

Let's shift gears to a cousin of the tetracyclines.

Section four, glycylcyclines.

Specifically, tagcycline.

Tagcycline is fascinating.

It's a synthetic analog.

Think of it as a tetracycline that went to the gym and got some armor.

OK, I like that analogy.

It was engineered specifically to bind to the ribosome, even when the bacteria tries to push it off.

So it works where tetracyclines fail.

It's for the really resistant bugs.

But there are limitations.

I'm seeing a big one right away.

Big ones.

It is IV only.

You cannot take this as a pill.

It is very high protein binding, up to 89 % and a massive volume of distribution.

It goes deep into the tissues, which is good, but it makes it hard to manage.

What about side effects?

Since it's a cousin, does it carry the same family baggage?

It carries the family baggage, photosensitivity, tooth discoloration, plus some extra GI issues.

Nausea and vomiting are extremely common with tagcycline.

I mean, really common.

Nurses often have to manage this aggressively with antibiotics.

And drug interactions.

Two to watch.

First, it decreases the effectiveness of oral contraceptives.

We sound like a broken record, but it's crucial.

You have to tell the patient.

Second, it interacts with warfarin.

It can clear the gut flora that produces vitamin K or interacts with metabolism, leading to increased warfarin levels.

That means the INR goes up and the patient bleeds much easier.

Okay.

So that covers the cyclines.

Now let's bring this down to the bedside.

Section five.

The nursing process for tetracyclines.

If I'm the nurse, what is my checklist?

What am I looking for?

Okay.

So assessment starts with the labs.

These drugs are processed by the liver and kidneys.

You absolutely need a baseline on BUN, creatinine, AST, ALT, and bilirubin.

If the kidneys are already failing, tetracyclines can make it worse.

And then the diet history.

You have to play detective.

Do you take vitamins?

Do you take Tums for heartburn?

Do you drink milk with every meal?

If they do, you don't necessarily have to ban those things, except maybe near the dosing time for the older drugs, but you have to create a schedule.

Right.

You have to space it out.

You have to space it out.

Take your pill at 8 a .m.

Take your antacid at 10 a .m.

You have to be that explicit.

And regarding interventions.

The golden rule of all antibiotics.

Get the culture and sensitivity, the CNS, before the first dose.

Before.

Always before.

Once you put the drug in, you skew the results.

We need to know exactly what bug we're fighting so we know if we're on the right track.

And patient teaching.

Storage,

keep it out of the sun, and heat to prevent that toxic breakdown we talked about.

Pregnancy warnings.

Make sure they understand this.

Sun protection.

Tell them to buy SPF 50.

Seriously.

And oral hygiene.

Tetracyclines can cause stomatitis mouth sores, so keeping the mouth clean is important.

And the contraception piece.

And the contraception piece.

If they're on the pill, they need a backup method like condoms.

You do not want a patient coming back cured of acne, but unexpectedly pregnant.

That's a bad outcome.

Fantastic.

That wraps up the Tetracyclines.

Now let's move on to the group that you labeled Heavy Artillery.

Section 6.

M &O glycosides.

Heavy Artillery is the only way to describe them.

Tetracyclines stop growth.

M &O glycosides kill.

They are bactericidal.

They inhibit bacterial protein synthesis, but they do it so aggressively that the bacterial cell wall integrity fails and the organism just dies.

So much more direct assault.

And what is their primary target?

They are hunters of gram -negative aerobic bacteria.

We're talking about the nasty hospital bugs.

E.

coli, proteus, and the dreaded Pseudomonas aeruginosa.

I've heard about Pseudomonas.

Pseudomonas is the bug that smells like grates but kills patients.

It lives in wet environments like ventilators and catheters.

It's a real problem.

The text mentions streptomycin as the first one, discovered in 1944.

That's a famous drug.

It is.

Streptomycin was a miracle drug for tuberculosis, for TB, and for the plague.

It earned its discoverers a Nobel Prize.

It was a game changer.

But we don't use it much anymore.

No.

Bacteria are smart.

Resistance developed pretty quickly, and the toxicity profile specifically, damage to the ears, became really apparent.

So today, streptomycin is rare.

You only see it for very specific things like tularemia or plague or multi -drug resistant TB.

It's not a daily driver anymore.

So for the modern nurse, what are the names we're hanging in the IV bags?

Jutamicin, tobromycin, and amicusin.

Those are the big three.

You will see these in the ICU constantly.

They're workhorses.

Let's look at the pharmacokinetics.

This is another area where that nurse thinking is vital.

Can I give these as a pill?

Generally, no.

And this comes down to basic chemistry.

Ammoglycosides are polycations.

They're very polar, very water soluble.

Meaning they don't cross fatty membranes.

Exactly.

They cannot cross the lipid membranes of the GI tract.

If you swallow a gentamicin pill,

it will travel through your gut and come out the other side essentially untouched.

You will not get therapeutic levels in the blood.

So it has to be injected.

For systemic infections, pneumonia, sepsis, they must be given IM or IV.

There's no other way to get them into the bloodstream.

I see neomycin listed here as oral drug.

So what's the deal with that?

That is the exception that proves the rule.

Why do we give neomycin orally?

Because it isn't absorbed.

So we're using that fact.

We're using its lack of absorption as a feature, not a bug.

We use it when we want to kill bacteria inside the bowel.

For example, before bowel surgery, we want to sterilize the gut to prevent infection if the surgeon accidentally nicks the intestine.

Or for hepatic coma.

Right, to reduce ammonia -producing bacteria in the gut.

We want the drug to stay in the gut.

We're using its primary limitation to our advantage.

That is a great distinction.

Five for the blood, oral only for the gut cleaning.

Now, what about the blood -brain barrier?

This is a crucial physiological difference.

In adults, aminoglycosides do not cross into the cerebrospinal fluid very well.

They aren't great for adult meningitis.

But in children, their blood -brain barrier is more permeable, and they do cross.

So that's a key age difference.

It is.

You have to be aware of that difference in distribution.

Let's focus on the prototype,

gentamisin sulfate.

Gentamisin is the workhorse.

It's cheap, it's effective, and it kills pseudomonas and MRSA.

But it has a very short half -life, usually about two hours.

That's really short.

It is.

This means the levels in the blood drop really quickly.

This requires frequent dosing or specific strategies, like extended interval dosing, to keep it effective.

This leads us directly to section seven, which I think is the most critical part of this entire chapter, toxicity and monitoring.

Yes.

This is where you earn your paycheck as a nurse.

Aminoglycosides have what's called a narrow therapeutic index.

Define that for us.

It means the difference between the dose that kills the bacteria and the dose that poisons the patient is razor thin.

So very little room for error.

Very little room for error.

You can't just eyeball this.

You have to be precise.

And what are the two major organs at risk here?

The ears and the kidneys.

Ototoxicity and nephrotoxicity.

Those are the big two.

Let's start with ototoxicity.

The ears.

These drugs can accumulate in the fluid of the inner ear.

They damage the delicate hair cells in the cochlea, which are for hearing, and the vestibular apparatus, which is for balance.

And that damage is permanent.

And here is the scary part.

Hair cells don't grow back.

The damage can be, and often is, permanent.

So if a patient complains of ringing in the ears?

That is tinnitus.

That is the ear raid siren.

If a patient on gentamicin says, my ears are ringing, or you sound muffled, or I feel dizzy, you stop the drug and you call the provider immediately.

You don't wait.

You do not wait.

You might be able to save your hearing if you catch it fast enough.

But if you ignore it and give two more doses, that patient might need hearing aids for the rest of their life.

And nephrotoxicity.

The kidneys.

The drug concentrates in the renal cortex.

It can cause acute tubular necrosis.

The kidneys just stop filtering.

This is usually reversible if you catch it.

But if you keep pushing the drug into failing kidneys, you can put them on dialysis.

This is why we rely so heavily on therapeutic drug monitoring,

or TDM.

Explain the peak and trough.

OK, imagine filling a bathtub that has a slow leak.

You need the water high enough to clean, which is killing the bacteria.

But if it overflows, it floods the house, which is toxicity.

OK, with you.

Peak is the high watermark.

We measure this about 45 to 60 minutes after the IV finishes infusing.

This tells us the maximum concentration the patient was exposed to.

If the peak is too high, we risk blowing out the ears and kidneys.

We are flooding the house.

And the trough.

Trough is the low watermark.

We measure this just minutes before we hang the next dose.

This tells us how well the kidneys cleared the previous dose.

If the trough is high, it means the kidneys haven't flushed the drug out yet.

The tub is still full.

So if you add another dose on top of that.

You will definitely overflow into toxicity.

A high trough is a major warning sign.

So high peak equals immediate overdose risk.

High trough equals accumulation risk because the kidneys are slow.

Exactly.

For gentamisin, the text gives strict numbers.

The peak should be between 5 and 8 micrograms per milliliter.

The trough should be less than 1 to 2.

If your trough comes back at 3 or 4, you hold the dose.

You call the pharmacy.

You call the doctor.

You have to wait for the tub to drain.

Before we leave this section, drug interactions.

There is a specific and kind of weird note about penicillins.

Yes.

This is a chemistry incompatibility.

Penicillins and aminoglycosides do not play nice together.

In fact, if you mix them in a beaker or an IV bag, the penicillin will chemically inactivate the aminoglycoside.

It just neutralizes it.

So never in the same IV bag.

Never.

Absolutely never.

And if you are running them into the same IV line, you have to flush the line thoroughly with saline between them.

Ideally, you space the dosing out by a few hours so they aren't peeking in the blood at the same time.

And warfarin again.

It seems to be on every list.

Same mechanism as before.

Aminoglycosides kill the gut flora, a vitamin K production drops, warfarin works too well, and the bleeding risk goes up.

You have to monitor the INR.

And loop diuretics.

This is a synergy of side effects, a very dangerous one.

Loop diuretics like ethychronic acid can also be ototoxic.

If you give a loop diuretic with an aminoglycoside, you are doubling the assault on the inner ear.

The risk of deafness goes way, way up.

You have to be extremely careful combining these.

OK, section eight.

Nursing process for aminoglycosides.

We've covered the peak in trough, but let's be specific about urine output.

How much are we looking for?

This is your early warning system for the kidneys.

The text states urine output must be at least 600 milliliter a day.

600 milliliter, that's roughly 25 milliliter per hour.

Which is actually quite low.

I mean, standard nursing logic usually looks for 30 milliliter per hour or more.

Yeah.

So if you are barely hitting 600 or you see a drop from the patient's baseline, say they were making a thousand milliliter yesterday and only 650 milliliter today,

that trend is alarming.

You report that immediately.

Immediately.

It means the kidneys are slowing down.

And what labs besides the drug levels?

BUN and creatinine, obviously, for the kidneys.

But also electrolytes.

Aminoglycosides can cause wasting of magnesium and potassium.

So you need to watch for hypomagnesemia and hypokalemia.

If a patient starts having muscle cramps or arrhythmias, check the electrolytes.

Moving on to our final major group,

section nine, floor quinolones.

Floor just quinolones, yeah.

These are fascinating because they attack the software, not the hardware.

They inhibit an enzyme called DNA gyrase.

What does DNA gyrase do?

Well, when bacteria try to replicate, their DNA is coiled up incredibly tight.

DNA gyrase is the enzyme that uncoils it so it can be copied.

Okay.

Floor quinolones jam that enzyme.

The DNA can't uncoil, it can't replicate, and the cell dies.

It is bactericidal.

It breaks the fundamental cycle of life for the bacteria.

The spectrum seems pretty broad.

It is.

They hit gram positives like streptococcus pneumonia and gram negatives like H influenza, Pseudomonas, Salmonella, and Shigella.

They're historically great for UTIs, bone and joint infections, and respiratory issues.

But there is a massive but here.

The black box warning.

Yes, the FDA dropped a hammer on these drugs a few years ago.

Floor quinolones are now reserved for patients with no other treatment options for uncomplicated infections like a simple UTI or sinusitis.

They're no longer a first -line choice for simple stuff.

Why the restriction?

What happened?

Because the side effects can be disabling and potentially irreversible.

The most famous one is tendon rupture.

It sounds almost like an urban legend, an antibiotic that snaps your Achilles tendon.

It disrupts the collagen matrix.

It actually weakens the structure of the tendon.

And yes, the Achilles is the most common site.

You can be walking down the hall and snap.

It's a real thing.

Who is most at risk?

The risk is highest in patients over 60.

Anyone taking corticosteroids like prednisone and organ transplant recipients.

So if a patient on Cipro says, hey, my heel hurts or my calf feels really tight.

You stop the drug immediately.

You immobilize the foot.

Do not let them walk on it.

You assume it's a rupture until it's proven otherwise.

This isn't a take some Tylenol situation.

This is stop the damage now.

What else is in that black box warning?

It can exacerbate myasthenia gravis.

It can literally paralyze the breathing muscles in those patients.

It can cause permanent peripheral neuropathy, numbness, and tingling that never goes away.

And it has significant CNS effects.

Dizziness, confusion, hallucinations, paranoia.

It can make elderly patients look like they have dementia overnight.

That's a scary list.

Let's look at the prototype.

Ciprofloxacin or Cipro?

Cipro is the classic.

It's rapidly absorbed.

But like tetracyclines, it has dietary interactions.

Absorption is reduced by antacids, iron, zinc, and calcium.

So take it two hours before or six hours after any of these products.

And drug interactions.

It creates a traffic jam in the liver.

It inhibits the enzymes that break down other drugs, specifically theophylline, which is an old asthma drug, and warfarin.

Of course, warfarin.

Of course.

If you take Cipro, your theophylline levels can spike, causing seizures and heart arrhythmias.

Your warfarin levels spike, causing bleeding.

You have to monitor these levels very closely if you start Cipro.

Section 10 looks at the newer fluoroquinolones.

We have levofloxacin.

Levo, yeah.

Levo is extremely common in hospitals.

It's often called a respiratory fluoroquinolone because it concentrates well in the lungs for pneumonia.

But there is a specific interaction note for levofloxacin regarding blood sugar.

It affects diabetics.

It messes with oral hypoglycemic, so diabetes pills.

It can cause severe hypoglycemia, dangerously low blood sugar.

If a diabetic patient is on levo, you have to monitor their finger sticks much more closely.

They might bottom out unexpectedly.

Then we have moxifloxacin.

Moxifloxacin is a once -a -day drug.

It's effective against some S -aureus.

But, and this is a critical distinction, it is not effective against VRE, which is vancomycin -resistant enterococcus.

Do not use it for VRE.

It simply won't work.

And delafloxacin.

This is a newer one for skin infections and pneumonia.

It carries all the same risks.

Tendon rupture, C.

diff diarrhea, and hyperglycemia.

It's another tool in the box, but it demands the same respect and caution.

So, section 11, nursing process for fluoroquinolones.

We have a unique urinary issue here.

Not just output, but crystals.

Yes, crystaluria.

Because the drug is excreted unchanged in the urine, if the patient is dehydrated, the drug can actually precipitate out of the liquid and form sharp crystals in the urine.

Like kidney stones made of antibiotic?

Essentially.

It causes physical damage to the kidney tubules and severe pain.

It literally cuts the tissue.

Ouch.

So how do we prevent that?

Hydration is the only way.

The text says fluid intake should be greater than 2 ,000 mL a day.

That's two liters.

You have to dilute the urine to keep the drug dissolved.

It's to keep it flowing.

Exactly.

We also want the urine pH below 6 .7, but volume is the main driver.

And for urine output, what's the minimum?

The safety threshold is 750 mL a day.

And notice that is higher than the aminoglycoside requirement of 600.

We need flow.

If they aren't peeing, you can't give the drug.

Any specific IV administration rules?

Yes.

You never push these fast.

You dilute it properly and you infuse it over 60 to 90 minutes.

A rabid infusion can cause hypotension and serious vein irritation.

Inpatient teaching.

Because of the dizziness and CNS effects, advise them to avoid driving or operating machinery until they know how the drug affects them.

Photosensitivity is a risk here, too.

Sunglasses and sunblock.

And advise them to avoid caffeine.

Caffeine?

Why caffeine?

Cipro slows down the breakdown of caffeine in the liver.

So if you drink your normal morning coffee while on Cipro, it might feel like you drank five espressos.

You'll be jittery, anxious, and your heart will race.

Warn them to switch to decaf for the week.

Okay.

We have covered the content.

Now let's put it to the test.

Section 12.

Clinical judgment.

We're going to walk through the case study provided in the text.

This is where the rubber meets the road.

I love these because this is real life.

This isn't theory anymore.

This is a person.

Here's the scenario.

We have a 46 -year -old female patient with a wound infection caused by Pseudomonas aeruginosa.

Her temperature is 104 degrees Fahrenheit, which is 40 Celsius.

She is prescribed Amikicin IV.

Okay, let's break it down.

High fever means she is systemic.

She's sick.

Pseudomonas is a difficult resistant bug.

Amikicin is an aminoglycoside, one of our heavy hitters.

This is an appropriate aggressive choice.

Question one is simple.

What is the drug classification?

You just answered it.

Aminoglycoside.

Right.

So immediately my brain goes ears and kidneys.

I'm already thinking about her urine output and her hearing before I even enter the room.

Question two, the math.

The patient weighs 165 pounds.

The dosage is 15 milligram kilo a day divided into three doses.

How much does she get per dose?

Okay, let's do this step by step.

Step one.

Step one, conversions.

We don't do pounds in medicine.

165 pounds divided by 2 .2 is 75 kilograms.

Okay, 75 kilos.

Step two, daily dose.

15 milligrams multiplied by 75 kilogram equals other 1 ,125 milligrams per day.

And step three is divided.

Right.

The order is divided into three doses, which usually means every eight hours.

So 11 ,125 divided by three equals 375 milligrams per dose.

375.

Got it.

Question three, IV details.

How do we give it?

We consult the general guidelines for aminoglycosides in the text.

You dilute it in D5W or normal saline, usually 100 to 200 millilo.

And you infuse it over 30 to 60 minutes.

You never slam an aminoglycoside.

You want to avoid a massive spike in peak levels that could trigger toxicity.

Question five, what are the similarities to gentamicin?

Like gentamicin, amikacin targets gram negatives like pseudomonas.

The key difference and why she might be on amikacin instead of gentamicin is resistance.

Amikacin is often less susceptible to the bacterial enzymes that disable gentamicin.

So it's the backup plan when the first line fails.

Question seven.

This is the critical thinking one.

The patient's urine output in the last eight hours was 125 millilo.

Is this a problem?

Let's look at the numbers.

125 millilo in eight hours.

If we project that out to 24 hours, 125 times three is 375 millilo for the whole day.

And what was our safety threshold for aminoglycosides?

600 millilo.

So she is way, way below the safety line.

She is at 375, the limit is 600.

This is huge.

It indicates oliguria.

Her kidneys are either taking a hit from the infection or she's severely dehydrated from the fever or the drug is already causing damage.

So nursing action, what do you do?

You hold the dose.

You absolutely hold the dose and you call the provider immediately.

Report the intake and output.

Dr.

Smith, Mrs.

Jones has only put out 125 millilo in the last eight hours.

Her amikacin is due.

I am holding it.

What do you want to do?

You do not administer that drug.

You advocate for your patient.

Question eight, peak and trough timing.

When do we draw the blood?

We draw the peak, come five to 60 minutes after the infusion finishes.

That tells us if the dose is too high.

We draw the trough just minutes before the next dose is hung.

That tells us that the kidneys are clearing it.

Excellent.

That case study really highlights how much calculation and monitoring goes into these drugs.

It's not passive at all.

You are managing the patient's physiology just as much as you're managing the infection.

All right, section 13, rapid fire review.

I'm going to ask a question based on the review section.

You give me the core concept.

Let's do it, Amy.

Patient is taking tetracycline.

They want to go to the beach.

What do you tell them?

Photosensitivity,

no sun or heavy sunscreen, long sleeves and a hat.

You will burn badly.

Patient is taking lever floxacin.

They complain of heel pain.

What is it?

Tendon rupture, stop the drug immediately, get them off their feet.

Patient is on gentamicin.

They say what?

A lot during your conversation.

What is the concern?

Ototoxicity, hearing loss or kinitis.

You need to check their hearing now.

Patient is on ciprofloxacin.

Why are we pushing fluids and measuring urine output so closely?

To prevent crystalluria.

Flesh those crystals out so they don't shred the kidneys.

Nailed it.

It all connects back to the mechanism and the chemistry.

If you understand the how, the why makes sense.

So let's wrap this all up.

We've covered four major classes of some pretty serious drugs.

I did.

First, tetracyclines, the broad spectrum pioneers.

Just remember bones, teeth and sun and don't mix with milk or tums.

Second, glycylcyclines.

Tauxycycline, the synthetic IV cousin for those really resistant bugs.

Watch out for severe nausea.

Third, aminoglycosides, the heavy artillery.

Gentamicin and amicicin, they're bactericidal.

And you have to watch the ears and kidneys like a hawk.

Peaks and troughs are mandatory, not optional.

And fourth, fluoroquinolones, Cipro and Levo, the DNA inhibitors.

And you have to watch out for tendons and crystalluria.

And remember the final encouragement.

Critical thinking is key.

Don't just give the drug.

Right.

Check the labs, especially the BUN and creatinine.

Check the diet.

Make sure there's no calcium or antacids near dose time for the problem drugs.

And check the patient.

Are they hearing?

Okay.

Does their heel hurt?

What's their urine output?

That is the difference between a pill dispenser and a nurse.

A hundred percent.

It's about seeing the whole picture.

A huge thank you to the Last Minute Lecture team for putting these notes together for us.

Always helpful.

And don't forget to review those tables in Chapter 28.

The specific dosages change.

And you really need to be familiar with the ranges for each drug.

Here's a final thought to leave you with.

We talked about how tetracyclines bind to calcium in teeth and bones.

And it makes you wonder if these drugs can become part of our physical structure, permanently changing the color of a tooth.

What does that say about the long -term chemical footprint of the treatments we use?

That's interesting.

We often think of drugs as things that just pass through us, but sometimes they become part of us.

A haunting thought for the road.

Thanks for listening to this deep dive.

Keep learning, stay curious, and we'll catch you on the next one.

Stay safe out there.